-
1
-
-
0001024770
-
Hereditary angioneurotic oedema
-
Osler W: Hereditary angioneurotic oedema. Am J Med Sci 1888, 95:362-367.
-
(1888)
Am J Med Sci
, vol.95
, pp. 362-367
-
-
Osler, W.1
-
2
-
-
50549190821
-
A biochemical abnormality in hereditary angioneurotic edema: Absence of serum inhibitor of C'1-esterase
-
Donaldson VH, Evans RR: A biochemical abnormality in hereditary angioneurotic edema: absence of serum inhibitor of C'1-esterase. Am J Med 1963, 35:37-44.
-
(1963)
Am J Med
, vol.35
, pp. 37-44
-
-
Donaldson, V.H.1
Evans, R.R.2
-
4
-
-
0036212766
-
Current management of hereditary angiooedema (C'1 esterase inhibitor deficiency)
-
Fay A, Abinun M: Current management of hereditary angiooedema (C'1 esterase inhibitor deficiency). J Clin Pathol 2002, 55:266-270.
-
(2002)
J Clin Pathol
, vol.55
, pp. 266-270
-
-
Fay, A.1
Abinun, M.2
-
5
-
-
0031712910
-
Molecular genetics of C'1-inhibitor
-
Tosi M: Molecular genetics of C'1-inhibitor. Immunobiology 1998, 199:358-365.
-
(1998)
Immunobiology
, vol.199
, pp. 358-365
-
-
Tosi, M.1
-
6
-
-
0031664687
-
Pathogenetic and clinical aspects of C1 inhibitor deficiency
-
Cicardi M, Bergamaschini L, Cugno M, et al.: Pathogenetic and clinical aspects of C1 inhibitor deficiency. Immunobiology 1998, 199:366-376.
-
(1998)
Immunobiology
, vol.199
, pp. 366-376
-
-
Cicardi, M.1
Bergamaschini, L.2
Cugno, M.3
-
7
-
-
34250714578
-
Search for factors affecting clinical manifestation of hereditary angioedema
-
Budapest, Hungary; April 7
-
Freiberger T, Grombirikova H, Kuklinek P, Litzman J: Search for factors affecting clinical manifestation of hereditary angioedema. Presented at the 12th Meeting of the European Society for Immunodeficiencies (ESID). Budapest, Hungary; April 7, 2006.
-
(2006)
Presented at the 12th Meeting of the European Society for Immunodeficiencies (ESID)
-
-
Freiberger, T.1
Grombirikova, H.2
Kuklinek, P.3
Litzman, J.4
-
9
-
-
0034661804
-
Hereditary angioedema with normal C1-inhibitor activity in women
-
Bork K, Barnstedt S, Koch P, Traupe H: Hereditary angioedema with normal C1-inhibitor activity in women. Lancet 2000, 356:213-217.
-
(2000)
Lancet
, vol.356
, pp. 213-217
-
-
Bork, K.1
Barnstedt, S.2
Koch, P.3
Traupe, H.4
-
10
-
-
33748149553
-
The therapeutic potential of a kallikrein inhibitor for treating hereditary angioedema
-
Levy JH, O'Donnell PS: The therapeutic potential of a kallikrein inhibitor for treating hereditary angioedema. Expert Opin Investig Drugs 2006, 19:1077-1090.
-
(2006)
Expert Opin Investig Drugs
, vol.19
, pp. 1077-1090
-
-
Levy, J.H.1
O'Donnell, P.S.2
-
11
-
-
0037333909
-
Bradykinin and the pathophysiology of angioedema
-
Cugno M, Nussberger J, Cicardi M, Agostoni A: Bradykinin and the pathophysiology of angioedema. Int Immunopharmacol 2003, 3:311-317.
-
(2003)
Int Immunopharmacol
, vol.3
, pp. 311-317
-
-
Cugno, M.1
Nussberger, J.2
Cicardi, M.3
Agostoni, A.4
-
12
-
-
0028909546
-
Unique C1 inhibitor dysfunction in a kindred without angioedema, II. Identification of an Ala443→Val substitution and functional analysis of the recombinant mutant protein
-
Zahedi R, Bissler JJ, Davis AE, et al.: Unique C1 inhibitor dysfunction in a kindred without angioedema, II. Identification of an Ala443→Val substitution and functional analysis of the recombinant mutant protein. J Clin Invest 1995, 95:1299-1305.
-
(1995)
J Clin Invest
, vol.95
, pp. 1299-1305
-
-
Zahedi, R.1
Bissler, J.J.2
Davis, A.E.3
-
13
-
-
0031570956
-
Role of the P2 residue of complement 1 inhibitor (Ala443) in determination of target protease specificity: Inhibition of complement and contact system proteases
-
Zahedi R, Wisnieski J, Davis AE: Role of the P2 residue of complement 1 inhibitor (Ala443) in determination of target protease specificity: inhibition of complement and contact system proteases. J Immunol 1997, 159:983-988.
-
(1997)
J Immunol
, vol.159
, pp. 983-988
-
-
Zahedi, R.1
Wisnieski, J.2
Davis, A.E.3
-
14
-
-
21344434308
-
C1 inhibitor deficiency: Consensus document
-
Gompels MM, Lock RJ, Abinun M, et al.: C1 inhibitor deficiency: consensus document. Clin Exp Immunol 2005, 141:189-190.
-
(2005)
Clin Exp Immunol
, vol.141
, pp. 189-190
-
-
Gompels, M.M.1
Lock, R.J.2
Abinun, M.3
-
16
-
-
27144463432
-
C1 inhibitor deficiency: Management
-
Gompels MM, Lock RJ: C1 inhibitor deficiency: management. Clin Exp Dermatol 2005, 30:737-740.
-
(2005)
Clin Exp Dermatol
, vol.30
, pp. 737-740
-
-
Gompels, M.M.1
Lock, R.J.2
-
17
-
-
0017077229
-
Hereditary angioedema: The clinical syndrome and its management
-
Frank MM, Gelfand JA, Atkinson JP: Hereditary angioedema: the clinical syndrome and its management. Ann Intern Med 1976, 84:580-593.
-
(1976)
Ann Intern Med
, vol.84
, pp. 580-593
-
-
Frank, M.M.1
Gelfand, J.A.2
Atkinson, J.P.3
-
18
-
-
0031041933
-
Side effects of long-term prophylaxis with attenuated androgens in hereditary angioedema: Comparison of treated and untreated patients
-
Cicardi M, Castelli R, Zingale LC, Agostoni A: Side effects of long-term prophylaxis with attenuated androgens in hereditary angioedema: comparison of treated and untreated patients. J Allergy Clin Immunol 1997, 99:194-196.
-
(1997)
J Allergy Clin Immunol
, vol.99
, pp. 194-196
-
-
Cicardi, M.1
Castelli, R.2
Zingale, L.C.3
Agostoni, A.4
-
19
-
-
0033608834
-
Hepatocelluar adenomas in patients taking danazol for hereditary angiooedema
-
Bork K, Pitton M, Harten P, Koch P: Hepatocelluar adenomas in patients taking danazol for hereditary angiooedema. Lancet 1999, 353:1066-1067.
-
(1999)
Lancet
, vol.353
, pp. 1066-1067
-
-
Bork, K.1
Pitton, M.2
Harten, P.3
Koch, P.4
-
20
-
-
16244384459
-
Adverse effects of danazol prophylaxis on the lipid profiles of patients with hereditary angioedema
-
Széplaki G, Varga L, Valentin S, et al.: Adverse effects of danazol prophylaxis on the lipid profiles of patients with hereditary angioedema. J Allergy Clin Immunol 2005, 115:864-869.
-
(2005)
J Allergy Clin Immunol
, vol.115
, pp. 864-869
-
-
Széplaki, G.1
Varga, L.2
Valentin, S.3
-
21
-
-
0038161137
-
Autoantibodies and lymphoproliferative diseases in acquired C1-inhibitor deficiencies
-
Cicardi M, Zingale LC, Pappalardo E, et al.: Autoantibodies and lymphoproliferative diseases in acquired C1-inhibitor deficiencies. Medicine (Baltimore) 2003, 82:274-281.
-
(2003)
Medicine (Baltimore)
, vol.82
, pp. 274-281
-
-
Cicardi, M.1
Zingale, L.C.2
Pappalardo, E.3
-
22
-
-
0027791794
-
Clinical problems in the C1-inhibitor deficient patient
-
Agostoni A, Cicardi M, Cugno M, Storti E: Clinical problems in the C1-inhibitor deficient patient. Behring Inst Mitt 1993, 93:306-312.
-
(1993)
Behring Inst Mitt
, vol.93
, pp. 306-312
-
-
Agostoni, A.1
Cicardi, M.2
Cugno, M.3
Storti, E.4
-
23
-
-
0015504576
-
Epsilon aminocaproic acid therapy of hereditary angioneurotic edema: A double blind study
-
Frank MM, Sergent JS, Kane MA, Alling DW: Epsilon aminocaproic acid therapy of hereditary angioneurotic edema: a double blind study. N Engl J Med 1972, 286:808-812.
-
(1972)
N Engl J Med
, vol.286
, pp. 808-812
-
-
Frank, M.M.1
Sergent, J.S.2
Kane, M.A.3
Alling, D.W.4
-
24
-
-
0142138728
-
How do we treat patients with hereditary angioedema?
-
Cicardi M, Zingale L: How do we treat patients with hereditary angioedema? Transfus Apheresis Sci 2003, 29:221-227.
-
(2003)
Transfus Apheresis Sci
, vol.29
, pp. 221-227
-
-
Cicardi, M.1
Zingale, L.2
-
25
-
-
0027317815
-
Treatment with tranexamic acid during pregnancy, and the risk of thrombo-embolic complications
-
Lindoff C, Rybo G, Astedt B: Treatment with tranexamic acid during pregnancy, and the risk of thrombo-embolic complications. Thromb Haemost 1993, 70:238-240.
-
(1993)
Thromb Haemost
, vol.70
, pp. 238-240
-
-
Lindoff, C.1
Rybo, G.2
Astedt, B.3
-
26
-
-
9644268117
-
Use of recombinant plasma kallikrein inhibitor in hereditary angioedema: A case report and review of the management of the disorder
-
Turner MD, Oughbourli A, Haeney K, Selvaggi T: Use of recombinant plasma kallikrein inhibitor in hereditary angioedema: a case report and review of the management of the disorder. J Oral Maxillofac Surg 2004, 62:1553-1556.
-
(2004)
J Oral Maxillofac Surg
, vol.62
, pp. 1553-1556
-
-
Turner, M.D.1
Oughbourli, A.2
Haeney, K.3
Selvaggi, T.4
-
27
-
-
27144499228
-
Emergency treatment of acute attacks in hereditary angioedema due to C1 inhibitor deficiency: What is the evidence?
-
Longhurst HJ: Emergency treatment of acute attacks in hereditary angioedema due to C1 inhibitor deficiency: what is the evidence? Int J Clin Pract 2005, 59:594-599.
-
(2005)
Int J Clin Pract
, vol.59
, pp. 594-599
-
-
Longhurst, H.J.1
-
28
-
-
4444318527
-
Hereditary angioedema: A half century of progress
-
Frank MM: Hereditary angioedema: a half century of progress. J Allergy Clin Immunol 2004, 114:626-628.
-
(2004)
J Allergy Clin Immunol
, vol.114
, pp. 626-628
-
-
Frank, M.M.1
-
29
-
-
0029973831
-
Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate
-
Waytes AT, Rosen FS, Frank MM: Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate. N Engl J Med 1996, 334:1630-1634.
-
(1996)
N Engl J Med
, vol.334
, pp. 1630-1634
-
-
Waytes, A.T.1
Rosen, F.S.2
Frank, M.M.3
-
30
-
-
0031820676
-
A randomized, controlled trial to study the efficacy and safety of C1 inhibitor concentrate in treating hereditary angioedema
-
Kunschak M, Engl W, Maritsch F, et al.: A randomized, controlled trial to study the efficacy and safety of C1 inhibitor concentrate in treating hereditary angioedema. Transfusion 1998, 38:540-549.
-
(1998)
Transfusion
, vol.38
, pp. 540-549
-
-
Kunschak, M.1
Engl, W.2
Maritsch, F.3
-
31
-
-
32844457999
-
Treatment with C1 inhibitor concentrate in abdominal pain attacks of patients with hereditary angioedema
-
Bork K, Meng G, Staubach P, Hardt J: Treatment with C1 inhibitor concentrate in abdominal pain attacks of patients with hereditary angioedema. Transfusion 2005, 45:1774-1784.
-
(2005)
Transfusion
, vol.45
, pp. 1774-1784
-
-
Bork, K.1
Meng, G.2
Staubach, P.3
Hardt, J.4
-
32
-
-
33646022921
-
Self-administration of C1-inhibitor concentrate in patients with hereditary and acquired angioedema caused by C1-inhibitor deficiency
-
Levi M, Choi G, Picavet MA, Hack CE: Self-administration of C1-inhibitor concentrate in patients with hereditary and acquired angioedema caused by C1-inhibitor deficiency. J Allergy Clin Immunol 2006, 117:904-908.
-
(2006)
J Allergy Clin Immunol
, vol.117
, pp. 904-908
-
-
Levi, M.1
Choi, G.2
Picavet, M.A.3
Hack, C.E.4
-
33
-
-
0142245455
-
Safety and efficacy of pasteurized C1 inhibitor concentrate (Berinert P) in hereditary angioedema: A review
-
De Serres J, Groner A, Lindner J: Safety and efficacy of pasteurized C1 inhibitor concentrate (Berinert P) in hereditary angioedema: a review. Transfus Apheresis Sci 2003, 29:247-254.
-
(2003)
Transfus Apheresis Sci
, vol.29
, pp. 247-254
-
-
De Serres, J.1
Groner, A.2
Lindner, J.3
-
34
-
-
33748984029
-
Hereditary angioedema managed with low-dose danazol and c1 esterase inhibitor concentrate: A case report
-
Altman AD, McLaughlin J, Schellenberg R, et al.: Hereditary angioedema managed with low-dose danazol and c1 esterase inhibitor concentrate: a case report. J Obstet Gynaecol Can 2006, 28:27-31.
-
(2006)
J Obstet Gynaecol Can
, vol.28
, pp. 27-31
-
-
Altman, A.D.1
McLaughlin, J.2
Schellenberg, R.3
-
36
-
-
25844432828
-
A phase I study of recombinant human C1 inhibitor in asymptomatic patients with hereditary angioedema
-
van Doorn MB, Burggraaf J, Van Dam T, et al.: A phase I study of recombinant human C1 inhibitor in asymptomatic patients with hereditary angioedema. J Allergy Clin Immunol 2005, 116:876-883.
-
(2005)
J Allergy Clin Immunol
, vol.116
, pp. 876-883
-
-
van Doorn, M.B.1
Burggraaf, J.2
Van Dam, T.3
-
37
-
-
33644820176
-
Recombinant human C1-inhibitor is effective in the treatment of acute attacks of hereditary angioedema - case report [in Polish]
-
Porebski G, Bilo B, Obtulowicz K, et al.: Recombinant human C1-inhibitor is effective in the treatment of acute attacks of hereditary angioedema - case report [in Polish]. Przegl Lek 2005, 62:317-320.
-
(2005)
Przegl Lek
, vol.62
, pp. 317-320
-
-
Porebski, G.1
Bilo, B.2
Obtulowicz, K.3
-
39
-
-
0032707505
-
A vote for inhaled adrenaline in the treatment of severe upper airway obstruction caused by piercing of the tongue in hereditary angioedema
-
Trachsel D, Hammer J: A vote for inhaled adrenaline in the treatment of severe upper airway obstruction caused by piercing of the tongue in hereditary angioedema. Intensive Care Med 1999, 25:1335-1336.
-
(1999)
Intensive Care Med
, vol.25
, pp. 1335-1336
-
-
Trachsel, D.1
Hammer, J.2
-
40
-
-
0142169427
-
DX-88 and HAE: A developmental perspective
-
Williams A, Baird LG: DX-88 and HAE: a developmental perspective. Transfus Apheresis Sci 2003, 29:255-258.
-
(2003)
Transfus Apheresis Sci
, vol.29
, pp. 255-258
-
-
Williams, A.1
Baird, L.G.2
-
41
-
-
31944445695
-
DX-88 a recombinant inhibitor of human plasma kallikrein: Efficacy and safety in hereditary and acquired angioedema
-
Cicardi M, González-Quivedo T, Caballero T, et al.: DX-88 a recombinant inhibitor of human plasma kallikrein: efficacy and safety in hereditary and acquired angioedema. Mol Immunol 2003, 40:197-198.
-
(2003)
Mol Immunol
, vol.40
, pp. 197-198
-
-
Cicardi, M.1
González-Quivedo, T.2
Caballero, T.3
-
42
-
-
31944437279
-
Anaphylactic reaction and antibodies to DX-88 (kallikrein inhibitor) in a patient with hereditary angioedema
-
Caballero T, López-Serrano C: Anaphylactic reaction and antibodies to DX-88 (kallikrein inhibitor) in a patient with hereditary angioedema. J Allergy Clin Immunol 2006, 117:476-477.
-
(2006)
J Allergy Clin Immunol
, vol.117
, pp. 476-477
-
-
Caballero, T.1
López-Serrano, C.2
-
43
-
-
0032490360
-
Plasma bradykinin in angio-oedema
-
Nussberger J, Cugno M, Amstutz C, et al.: Plasma bradykinin in angio-oedema. Lancet 1998, 351:1693-1697.
-
(1998)
Lancet
, vol.351
, pp. 1693-1697
-
-
Nussberger, J.1
Cugno, M.2
Amstutz, C.3
-
44
-
-
33644773297
-
Current treatment of HAE and future treatment options
-
Bork K: Current treatment of HAE and future treatment options. J Allergy Clin Immunol 2007, 113:S94-S96.
-
(2007)
J Allergy Clin Immunol
, vol.113
-
-
Bork, K.1
-
45
-
-
33750526677
-
Novel pharmacotherapy of acute hereditary angioedema with bradykinin B2-receptor antagonist icatibant
-
Bas M, Bier H, Greve J, et al.: Novel pharmacotherapy of acute hereditary angioedema with bradykinin B2-receptor antagonist icatibant. Allergy 2006, 61:1490-1492.
-
(2006)
Allergy
, vol.61
, pp. 1490-1492
-
-
Bas, M.1
Bier, H.2
Greve, J.3
-
46
-
-
31544445804
-
B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus
-
Eisenberg R, Albert D: B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus. Nat Clin Pract Rheumatol 2006, 2:20-27.
-
(2006)
Nat Clin Pract Rheumatol
, vol.2
, pp. 20-27
-
-
Eisenberg, R.1
Albert, D.2
-
47
-
-
28944435507
-
Images in clinical medicine. Pemphigus foliaceus
-
Johnston S, Kennedy C: Images in clinical medicine. Pemphigus foliaceus. N Engl J Med 2005, 353:2589.
-
(2005)
N Engl J Med
, vol.353
, pp. 2589
-
-
Johnston, S.1
Kennedy, C.2
-
50
-
-
33746447184
-
Rituximab-induced elimination of acquired angioedema due to C1-inhibitor deficiency
-
Levi M, Hack CE, van Oers MH: Rituximab-induced elimination of acquired angioedema due to C1-inhibitor deficiency. Am J Med 2006, 119:e3-e5.
-
(2006)
Am J Med
, vol.119
-
-
Levi, M.1
Hack, C.E.2
van Oers, M.H.3
-
51
-
-
33644808958
-
A novel series of arylsulfonylthiophene-2-carboxamidine inhibitors of the complement component C1s
-
Subasinghe NL, Travins JM, Ali F, et al.: A novel series of arylsulfonylthiophene-2-carboxamidine inhibitors of the complement component C1s. Bioorg Med Chem Lett 2006, 16:2200-2204.
-
(2006)
Bioorg Med Chem Lett
, vol.16
, pp. 2200-2204
-
-
Subasinghe, N.L.1
Travins, J.M.2
Ali, F.3
-
52
-
-
33750991095
-
Discovery of highly potent small molecule kallikrein inhibitors
-
Zhang J, Krishnan R, Arnold CS, et al.: Discovery of highly potent small molecule kallikrein inhibitors. Med Chem 2006, 2:545-553.
-
(2006)
Med Chem
, vol.2
, pp. 545-553
-
-
Zhang, J.1
Krishnan, R.2
Arnold, C.S.3
|